CCKBR agonist-1
CCKBR agonist-1 (Compound 3r1) is a Gq-protein-preferring cholecystokinin B receptor (CCKBR) agonist with an EC50 of 35 pM. CCKBR agonist-1 significantly increases the survival rate of neurons, with an EC50 of 37 pM. CCKBR agonist-1 can improve the cognitive decline in mice by upregulating α-secretase (ADAM10) and calcium signaling molecule PLCB4, reduce the number of amyloid β (Aβ) plaques, and promote long-term potentiation (LTP) . CCKBR agonist-1 can be used for the study of Alzheimer's disease[1].
Product Specifications
CAS Number
[2923120-30-1]
UNSPSC
12352209
Target
Amyloid-β; Cholecystokinin Receptor; MMP
Related Pathways
GPCR/G Protein; Metabolic Enzyme/Protease; Neuronal Signaling
Field of Research
Neurological Disease
Smiles
O=C(N[C@@H](CC1=CNC2=CC=CC=C12)C(N[C@@H](CCCC)C(N[C@@H](CC(O)=O)C(N[C@@H](CC3=CC(Br)=CC=C3)C(N)=O)=O)=O)=O)C
Molecular Formula
C32H39BrN6O7
Molecular Weight
699.59
References & Citations
[1]Wang JL, et al. Elucidating pathway-selective biased CCKBR agonism for Alzheimer's disease treatment. Cell. 2025 Nov 20:S0092-8674 (25) 01238-3.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Isoform
ADAM10; CCKBR
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
SFRS3, ID (SRSF3, SFRS3, SRP20, Serine/arginine-rich splicing factor 3, Pre-mRNA-splicing factor SRP20, Splicing factor, arginine/serine-rich 3) (PE) discontinued
![Mouse Monoclonal ABCG2/CD338 Antibody (3G8) [DyLight 680]](https://cdn.genprice.uk/genprice/uk/genprice4.webp)
